Skip to main content

Table 3 The risk factors in predicting patients with mild to moderate SARS-CoV-2 pneumonia conversion rate to severe cases

From: Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study

Variable Regression coefficient Standard error P value Odds ratio Lower OR Upper OR
Age, years -0·04 0·04 0·2376 0·96 0·90 1·03
Gender (female vs. male) −1·38 0·76 0·0702 0·25 0·06 1·12
Fever (yes vs. no) 1·13 0·60 0·0597 3·09 0·96 9·99
Comorbidities (yes vs. no) 0·87 0·86 0·3121 2·38 0·44 12·76
C-reactive protein (< 10 mg/L vs.10 mg/L) 0·38 0·75 0·6145 1·46 0·33 6·40
Lymphocyte count (per reduced 0·1 × 109/L) −0·25 0·09 0·0070 0·78 0·65 0·94
Time from onset of illness to antiviral treatment, days 0·03 0·06 0·6670 1·03 0·91 1·17
Corticosteroids (yes vs. no) −1·99 0·90 0·0275 0·14 0·02 0·80